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E-mail address: laurent.debelle@univ-reims.fr (L. DElastin peptides regulate proliferation, chemotaxis and protease expression. The aim of this work
was to assess their inﬂuence on apoptosis. Human skin ﬁbroblast cell death was induced using
C2-ceramide in the presence or absence of elastin peptides. We show that ceramide-induced apop-
tosis could be blocked by elastin peptides. Using pharmacological inhibitors, we show that elastin
peptide treatment leads to activation of the anti-apoptotic protein Akt that phosphorylates the
pro-apoptotic protein Bad, the Foxo3a transcription factor and caspase-9. Importantly, the anti-
apoptotic effects of elastin peptides were persistent in time. Our results suggest that elastin peptides
could be potent cell survival factors.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
With aging, normal cells experience cumulative stresses due to
environmental, nutritional or genetic modiﬁcations [1]. So, they
accumulate damaged structures [2], that, depending on their
severity, are either eliminated by autophagy or trigger apoptosis
onset [3]. As a consequence, normal cells have a ﬁnite lifespan
and typically die by undergoing apoptosis or enter into a state of
irreversible growth arrest, termed replicative senescence [1].
The extracellular matrix plays a critical role in cell fate [4]. It al-
lows them to adhere, provides a scaffold for their migration and
fragments from its degradation, matrikines, can orient cell
behavior.
Elastin is the extracellular matrix protein responsible for the
elasticity of tissues. It is abundant in tissues such as skin, lung or
large arteries. It is constituted of tropoelastin molecules covalently
bound to each other by covalent cross-links [5]. It is a very durablechemical Societies. Published by E
ulbecco’s modiﬁed Eagle’s
ptides; ERC, elastin receptor
LICA, ﬂuorescent inhibitor of
xtracellular signal-regulated
nositol 3-kinase
ebelle).polymer experiencing essentially no turnover in healthy tissues
[6].
Be it due to tear and wear or to the action of elastases, elastin
fragmentation is a hallmark of aging and the blood concentration
of elastin peptides (EP) increases with age [7]. At the difference
of elastin, EP can modulate the behavior of various cells.
The elastin receptor complex (ERC) comprises an elastin bind-
ing protein (EBP), neuraminidase-1 (Neu-1) and cathepsin A/pro-
tective protein [8]. EBP is an enzymatically inactive, spliced
variant of b-galactosidase [9]. It binds EP with high afﬁnity but
the elastin-EBP interaction can be regulated by galactosugars. Con-
sequently, lactose is a commonly used antagonist of EBP. The cat-
alytical activity of Neu-1 is crucial for EBP signaling [10].
Besides EBP, integrin avb3 and galectin-3 have been proposed
to mediate EP signals. The integrin avb3 recognizes a broad range
of proteins [11]. It binds tropoelastin in a 16-residue region found
at its C-terminus [12]. This suggests that avb3 could participate to
elastogenesis. Additionally, EP could bind to avb3 and mediate a
part of their effects [13]. Galectin-3 is mostly expressed in inﬂam-
matory cells [14]. It has been recently shown that the VGVAPG
elastin peptide could bind to galectin-3, leading to melanoma inva-
sion [13]. Finally, nonapeptides derived from elastin could induce
macrophage migration via an undeﬁned lactose-insensitive recep-
tor [15].
Aging is marked by important changes in ceramide production
[16]. At low concentrations, these compounds promote celllsevier B.V. All rights reserved.
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Several studies have underlined that ceramides accumulate in tis-
sues with aging eventually promoting apoptosis [17].
Previous results from our group have shown that the treat-
ment of human skin ﬁbroblasts with EP leads to the activation
of the PI3 K p110c [18]. PI3K p110c is known to be an activator
of Akt, a strong anti-apoptotic kinase [19]. In this cellular system,
this effect seems to be processed solely by the elastin complex
receptor as both lactose and invalidation of Neu-1 blocked it
[10].
The effect of EP on cell survival has never been envisaged. In this
work, we hypothesized that the increased level of EP observed with
age could promote cell survival and in some way restrain the apop-
totic signals brought by ceramides. In so doing, EP would promote
senescence of damaged cells and thereby contribute to global tis-
sue aging.Fig. 1. Flow cytometry analysis of EP effects on C2-cer-induced apoptosis. Human
skin ﬁbroblasts were incubated with annexin V-FITC and 7AAD and analysed by
ﬂow cytometry. Cell survival is estimated as a percentage value determined from
quadrant 3. Early and late apoptotic cells correspond to quadrants 4 and 2,
respectively. (A) Cells without treatment (control). (B) Cells after incubation with
C2-cer (20 lM) for 20 h. (C) Cells after incubation with C2-cer (20 lM) for 20 h in the
presence of EP (50 lg/ml). (D) Cells after incubation with C2-cer (20 lM) for 20 h in
the presence of EP (50 lg/ml) and lactose (1 mM). (E) Cells after incubation with C2-
cer (20 lM) for 20 h in the presence of EP (50 lg/ml) and U0126 (10 lM). (F) Cells
after incubation with C2-cer (20 lM) for 20 h in the presence of EP (50 lg/ml) and
LY294002 (25 lM).2. Materials and methods
2.1. Materials
Lactose, propidium iodine, N-acetyl-D-sphingosine (C2-cera-
mide, C2-cer) and mouse monoclonal anti-b-actin antibody were
from Sigma (St-Quentin-en-Yvelines, France). LY294002, U0126,
rabbit polyclonal phospho-speciﬁc antibodies against Akt (phos-
phorylated on T308 and S473), Bad (phosphorylated on S136)
and Foxo3a (phosphorylated on S253) were from Cell Signaling
Technology Inc. (distributed by Ozyme, Montigny-le-Bretonneux,
France). Annexin V-FITC kit was from Miltenyi Biotec (Paris,
France). 7-Aminoactinomycin D (7AAD) was from Interchim
(Montluçon, France). The rabbit polyclonal phospho-speciﬁc anti-
body against caspase-9 (phosphorylated on S196) was from San-
ta-Cruz technology (distributed by Tebu, Le-Perray-en-Yvelines,
France).
2.2. Elastin peptides preparation
EP were prepared as described previously [20]. The obtained
mixture of EP exhibits the same biological properties as elastin
hydrolysates obtained with elastases [20]. In this preparation, elas-
tin chains cleavage is random, and consequently, this peculiar EP is
thought to present every type of bioactive elastin fragments what-
ever the receptor they target (lactose sensitive or not).
2.3. Cell culture and treatments
Human skin ﬁbroblast strains were established from explants of
human adult skin biopsies obtained from informed healthy volun-
teers. Cells were grown as monolayer cultures in Dulbecco’s mod-
iﬁed Eagle’s medium (DMEM GlutaMax) supplemented with 10%
fetal calf serum in the presence of 5% CO2. Cells at subcultures 5–
10 were used. For experiments, ﬁbroblasts were grown to subcon-
ﬂuence in 10% serum containing medium. Before stimulation, cells
were incubated for 24 h in DMEM without fetal calf serum. The
pharmacological inhibitors LY294002 (25 lM) and U0126
(10 lM) were preincubated for 1 h before stimulation, whereas
lactose (1 mM) was preincubated for 3 h.
2.4. Flow cytometry
For the analysis of apoptosis, annexin V-FITC kit was used in
accordance with the protocol provided by the supplier except that
7AAD was incubated for 10 min instead of propidium iodine. Fluo-
rescence was analyzed by ﬂuorescence-activated cell sorter FAC-
Scalibur cytometer (BD Biosciences).2.5. Western blotting
Cells were washed twice in ice-cold PBS containing 50 lM
Na3VO4, scrapped, and sonicated in lysis buffer (PBS, pH 7.4,
0.5% Triton X-100, 80 mM glycerophosphate, 50 mM EGTA,
15 mM MgCl2, 1 mM Na3VO4, and protease inhibitor cocktail).
Insoluble material was removed by centrifugation (20 000g,
20 min, 4 C). Protein concentrations were determined by bicinch-
oninic acid protein assay (Pierce Chemical, Rockford, IL; distrib-
uted by Interchim, Montluçon, France). Equal amounts of
proteins were heated for 5 min at 100 C in Laemmli sample buf-
fer, resolved by SDS–PAGE under reducing conditions, and trans-
ferred to nitrocellulose membranes. The membranes were
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fered saline/Tween 20 (50 mM Tris, pH 7.5, 150 mM NaCl, and
0.1% (v/v) Tween 20)] for 1 h at room temperature and incubated
overnight at 4 C with anti-phospho-T308-Akt (1:400), anti-phos-
pho-S473-Akt (1:400), anti-phospho-S136-Bad (1:500), anti-phos-
pho-S253-Foxo3a (1:400), anti-phospho-S196-caspase-9 (1:200)
or anti-b-actin (1:5000) antibodies. After ﬁve washings with
Tris-buffered saline/Tween 20, the membranes were incubated
for 1 h at room temperature in the presence of horseradish perox-
idase-coupled anti-rabbit or anti-mouse antibodies (1:1000 and
1:10 000 in blocking buffer, respectively). Immunocomplexes
were detected by chemiluminescence. In order to evaluate the
phosphorylation time course, the bands were analyzed semi-
quantitatively using the densitometric Phosphor Analyst software
(Bio-Rad, Marne-la-Vallée, France).Fig. 2. Activation of Akt and subsequent signaling induced by EP. Human skin ﬁbroblas
were then lysed and proteins were extracted and subjected to Western blot analysis. Blot
Effect of EP on Akt phosphorylation. Western-Blot analysis of Akt phosphorylation was pe
(B) Effect of EP on Bad and caspase-9 phosphorylation. Western-Blot analysis was perform
antibodies. (C) Effect of EP on Foxo3a phosphorylation. Western-Blot analysis of Foxo3
loading was assessed for each blot using an anti-b-actin antibody (1:5000).2.6. Caspase activity
Caspase-9 activity analysis was carried out using the ﬂuoro-
chrome inhibitor of caspase (FLICA) apoptosis detection from
AbD Serotec (distributed by e-biosciences, San Diego, USA). Cells
were seeded in 12 wells plates at the bottom of which blades of
microscopes were placed. Before stimulation, cells were incubated
for 24 h in DMEM without fetal calf serum. The medium was then
removed and replaced by a new medium containing a solution of
30X FLICA at a ratio of 1:30. Cells were incubated for 1 h at 37 C
and 5% CO2. The medium was removed and replaced by a medium
containing Hoechst 33342 (0.5% v/v) in order to label nuclei. Cells
were incubated 5 min at 37 C and 5% CO2. The medium was re-
moved and the cells underwent two washings before ﬁxing with
the reagent that comes with the kit. Cells were placed under a ﬂuo-ts were incubated in the absence or presence of EP (50 lg/ml) for 0–240 min. Cells
s are presented with their corresponding b-actin blot and densitometric analysis. (A)
rformed using anti-phospho-T308-Akt (1:400) and anti-phospho-S473-Akt (1:400).
ed using anti-phospho-S136-Bad (1:500) and anti-phospho-S196-caspase-9 (1:400)
a phosphorylation was performed using anti-phospho-S253-Foxo3a (1:400). Equal
Fig. 2 (continued)
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Fig. 3. EP block C2-cer-induced caspase-9 activity. Cells were cultured in the presence or absence of EP (50 lg/ml) and C2-cer (20 lM) for 4 h. The cell permeable FLICA
reagent was then allowed to diffuse in the culture medium and covalently bound to active caspase-9. Its ﬂuorescence was excited at 490 nm and detected at 520 nm. Nuclei
were visualized with Hoechst staining using an excitation at 365 nm and detection at 480 nm. Bar, 100 lm.
B. Cantarelli et al. / FEBS Letters 583 (2009) 2385–2391 2389rescence microscope using an excitation at 490 nm and ﬂuores-
cence detection at 520 nm. Hoechst staining was observed using
an excitation at 365 nm and detection at 480 nm.
3. Results
3.1. EP block ceramide-induced apoptosis through PI3 K signaling
Apoptosis of human skin ﬁbroblasts was induced using 20 lM
C2-cer for 20 h and quantitatively analyzed using ﬂow cytometry
(Fig. 1).
In the absence of treatment (Fig. 1A), the survival rate was esti-
mated to 86%. This rate fell drastically to 5% when cells were trea-
ted with C2-cer for 20 h (Fig. 1B). Interestingly, the pro-apoptopic
effects of C2-cer was strongly attenuated (28% versus 5%) when
EP were present in the medium (Fig. 1C). In order to address the
importance of the ERC in this phenomenon, stimulation of cells
with both C2-cer and EP was performed in the presence of 1 mM
lactose (Fig. 1D). In this condition, the protective effect of EP
against C2-cer-induced apoptosis was reduced (15% versus 28%)
indicating that the ERC could contribute to this effect. Galectin-3
could be excluded as we had shown earlier that ERC was the recep-
tor driving EP effects in human skin ﬁbroblasts [10].
We have previously shown [18] that the stimulation of human
skin ﬁbroblasts with EP triggers the MEK/ERK and the PI3 K/p110c
pathways which are known to promote cell survival [21]. Blocking
the MEK/ERK pathway using U0126 (Fig. 1E) slightly lowered the
ability of EP to restrain C2-cer-induced apoptosis (38% versus
28%). We concluded that the MEK/ERK pathway was not critically
involved. The use of LY294002, a pharmacological PI3 K inhibitor
(Fig. 1F), strongly reduced the protective effect of EP (10% versus
28%) and returned to a value close to that observed in the absence
of EP treatment. So, we concluded that the anti-apoptotic effect of
EP on human skin ﬁbroblast was mainly transduced by p110c.
3.2. EP induce Akt signaling
The Akt kinase [22] is one of the main targets of PI3 K. It is acti-
vated by phosphorylation on T308 and S473 and, in turn, phos-
phorylates and inactivates targets such as the pro-apoptotic
protein Bad, the Foxo3a transcription factor and caspase-9.
The treatment of cells with EP induced rapid Akt phosphoryla-
tion at T308 (Fig. 2A). In contrast, S473 phosphorylation could
not be observed until 30 min. Full activation of Akt was thus
reached at 30 min. Interestingly, these effects were persistent in
time as they could still be observed at 4 h.
Bad is a member of the Bcl-2 apoptosis-regulating proteins. In
the absence of phosphorylation, Bad is found localized to the mito-chondria bound to Bcl-2 and Bcl-XL, where it can induce cell death.
Its phosphorylation on S136 by Akt leads to the loss of its pro-
apoptotic properties [23]. Foxo3a is a Forkhead family transcrip-
tion factor involved in the expression of pro-apoptotic proteins
[24]. Its phosphorylation by Akt abrogates its function as a tran-
scription factor. Caspase-9 is a protease involved in the intrinsic
apoptotic pathway [25]. Its phosphorylation on S196 by Akt inhib-
its its pro-apoptotic activity [26].
The phosphorylation of Bad and caspase-9 were modiﬁed by the
treatment of cells with EP (Fig. 2B). Maximum phosphorylation of
both Akt targets was observed at 15 min. Their intensity decreased
at 30 min and increased back at 4 h. Strikingly, the time course of
their phosphorylation were comparable.
EP treatment also changed the phosphorylation of Foxo3a
(Fig. 2C). A small increase could be detected at 5 min but maximum
phosphorylation of Foxo3a was reached at 30 min. This effect was
still present after 4 h of treatment.
Altogether, these data suggest that EP treatment activated Akt
activity which, in turn, phosphorylated and led to the inactivation
of the pro-apoptotic targets Bad, Foxo3a and caspase-9.
3.3. EP block C2-cer-induced caspase activation
Caspase-9 activity in cells was investigated using the FLICA re-
agent method. In the absence of treatment, caspase-9-positive cells
could not be evidenced (Fig. 3A). In contrast, the treatment with
C2-cer for 4 h (Fig. 3B) induced an important caspase-9 labeling
consistent with apoptosis induction. When the same treatment
was performed in the presence of EP, caspase-9 activation was con-
siderably reduced (Fig. 3C). These results were consistent with our
previous observations suggesting that EP could block C2-cer-in-
duced apoptosis.
4. Discussion
The role of EP is still a matter of discussion as these matrikines
exhibit a broad range of biological activities. In some cases, their
action seems to be detrimental for the subject, for instance they
promote aneurism progression [27], but in other cases they dem-
onstrate powerful beneﬁcial effects such as in ischemia recovery
[28]. Friends or foes? The discussion is still opened and the answer
most certainly lies between these two extremities depending on
the considered context.
We had shown previously that EP could strongly inﬂuence the
behavior of human skin ﬁbroblasts and that their effect involved
both the PI3 K p110c and the MEK/ERK pathway [18]. As these
two kinases have been linked to cell survival, we hypothesized that
EP could contribute to cell survival.
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This system has been extensively studied and we have previously
shown that EP effect on these cells was mostly mediated by the
ERC. Indeed, blocking Neu-1 activity, which is required for proper
ERC signaling, by over-expression of an inactive form of Neu-1 or
by using a Neu-1 siRNA blocked EP effects [10].
Our results show that EP are potent pro-survival factors as they
are able to efﬁciently block ceramide-induced apoptosis (Fig. 1).
The fact that lactose could block their effect strongly suggests that
it is processed by the EBP sub-unit of the ERC. Importantly, we
show here that the effects triggered by EP are mostly dependent
on PI3 K activity. This point suggested that the signals processed
by the ERC following EP binding involved p110c. This PI3 K is a ma-
jor actor of chemotaxis [29], a phenomenon that can be promoted
by EP. Additionally, it is involved in angiogenesis [30], ischemia
reperfusion injury recovery [28] and proteases production by EP
[18]. Our results support the fact that this kinase holds a pivotal
role in EP biology.
The anti-apoptotic kinase Akt is the main downstream target of
PI3 K. Our data indicate that EP treatment promotes Akt activation
(Fig. 2A). Interestingly, Akt activation following EP treatment was
persistent in time and could be observed after 4 h. This point sup-
ported our view that EP were potent anti-apoptotic molecules. In
keeping with this result, we observed that EP also induced the
phosphorylation of Bad, Foxo3a and caspase-9, three pro-apoptotic
targets of Akt (Fig. 2B).
Altogether, our data suggest that EP promote cell survival by the
p110c/Akt pathway and subsequent blocking of the intrinsic (Bad,
caspase-9) and extrinsic (Foxo3a) apoptotic pathways. Interest-
ingly, the phosphorylation of intrinsic pathway targets was maxi-
mum at 15 min, and despite a decrease observed at 30 min, it
returned back at 4 h. This peculiar phosphorylation pattern seems
to indicate that EP effects could somehow modulate the kinase/
phosphatase balance which would explain the ﬂuctuating phos-
phorylation levels observed. Further data are needed to address
this hypothesis.
As we had shown previously that the anti-apoptotic effects of
EP were persistent in time, we analyzed caspase-9 activity after
4 h of treatment (Fig. 3). Our results demonstrate that EP effects
are still present and strong after a long period of exposure to EP.
This point is very important as it suggests that EP effects are not
cleared rapidly and this could have important consequences.
Under normal circumstances, cells that have accumulated dam-
aged structures are eliminated by apoptosis [3]. Aging cells are also
known to accumulate lipids, notably ceramides that can eventually
lead to apoptosis [1]. As our data show it, EP can efﬁciently reduce
the apoptotic signals initiated by ceramides. So, their presence in
the environment of aged cells could contribute to their escape from
apoptosis. This would then facilitate the entering of these damaged
cells in the senescent state.
Senescent cells exhibit typical characteristics. Their growth is
arrested. They are resistant to apoptosis and they present an al-
tered gene expression pattern [31]. At the difference of apoptotic
cells which are eliminated by the organism, senescent cells remain
in the tissue. And because they are not normal cells, their altered
functions can contribute to the alteration of the microenvironment
and promote the cancer or aging phenotype [32]. For instance,
senescent ﬁbroblasts can alter epithelial cell differentiation [33].
The loss of tissue function, which is a hallmark of aging, could thus
be due, at least in part, to the accumulation of senescent cells in tis-
sues [31].
As a consequence, we suggest that the increasing presence of EP
with age could block signals intended at disposal of damaged cells
and would thereby promote senescence entering by these cells. As
such, they could contribute to the modiﬁcation of tissue homeosta-
sis observed with aging.Besides this detrimental effect, the fact that EP promote cell sur-
vival could be very important in wound healing as locally produced
peptides would durably sustain cell survival at the local site of in-
jury. This could be the explanation of what is observed during
ischemia reperfusion [28]. The hypothesis that EP could help
wound healing needs further investigation.
To our knowledge, the effect of EP on cell survival had never
been envisaged. Our work clearly demonstrates that these matri-
kines are potent survival factors for human skin ﬁbroblasts as their
effects are strong and persistent in time. As a consequence, our
data suggest that their increasing presence with age could pro-
foundly change tissue homeostasis and contribute to global tissue
aging.
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